Stay updated on VB-111 Combo in Recurrent Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2Fu4Ji_6STQHK3eA0lqf0FCCS8YdY.uncropped.jpg&w=3840&q=75)
Latest updates to the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has expanded to include 57 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference0.4%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check32 days agoChange DetectedThe recent change in the webpage value from 'Show more Revision: v2.9.0' to 'Genetic and Rare Diseases Information Center resources: Glioblastoma, Glioma, Neuroepithelioma, Drug Information available for: Bevacizumab, FDA Drug and Device Resources' represents an update in the study details section, specifically highlighting additional resources and information related to the treatment options and diseases covered in the clinical trial.SummaryDifference14%
Stay in the know with updates to VB-111 Combo in Recurrent Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VB-111 Combo in Recurrent Glioblastoma Clinical Trial page.